ASY202 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03 (month) in 4mo
ESTIMATED |
READOUT
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergota
Phase 2 · Migraine |
Aspeya, Inc. | ASY202 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-31
Sponsor-projected date — can change
|